Finance

Lists
0A9W:LON
Organon & Co
13,77 $
+0,07%
(+0,010) 1D
16 հոկ, 19:05:06 GMT+1  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for 0A9W...
Open
13,76 $
High
13,78 $
Low
13,76 $
Mkt. cap
3,61 մլրդ
Avg. vol.
3,86 հզր
Volume
65,00
52-wk high
13,78 $
52-wk low
9,19 $
No. of employees
10 հզր
Open
13,76 $
High
13,78 $
Low
13,76 $
Mkt. cap
3,61 մլրդ
Avg. vol.
3,86 հզր
Volume
65,00
52-wk high
13,78 $
52-wk low
9,19 $
No. of employees
10 հզր
News stories
From web sources and news partners
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10 հզր
Founded1923
HeadquartersՋերսի Սիթի, Նյու Ջերսի, Միացյալ Նահանգներ
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
1,60 մլրդ
1,51 մլրդ
1,46 մլրդ
1,56 մլրդ
Cost of goods sold
733,00 մլն
741,00 մլն
670,00 մլն
711,00 մլն
Cost of revenue
733,00 մլն
741,00 մլն
670,00 մլն
711,00 մլն
Research and development expenses
84,00 մլն
91,00 մլն
93,00 մլն
90,00 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
415,00 մլն
431,00 մլն
424,00 մլն
434,00 մլն
Operating expense
499,00 մլն
522,00 մլն
517,00 մլն
524,00 մլն
Total operating expenses
1,23 մլրդ
1,26 մլրդ
1,19 մլրդ
1,24 մլրդ
Operating income
370,00 մլն
244,00 մլն
273,00 մլն
323,00 մլն
Other non operating income
30,00 մլն
-18,00 մլն
15,00 մլն
-3,00 մլն
EBT including unusual items
243,00 մլն
-148,00 մլն
213,00 մլն
183,00 մլն
EBT excluding unusual items
255,00 մլն
103,00 մլն
170,00 մլն
210,00 մլն
Income tax expense
83,00 մլն
57,00 մլն
67,00 մլն
75,00 մլն
Effective tax rate
34,16%
-38,51%
31,46%
40,98%
Other operating expenses
-
-
-
-
Net income
160,00 մլն
-205,00 մլն
146,00 մլն
108,00 մլն
Net profit margin
9,99%
-13,60%
10,00%
6,93%
Earnings per share
1,01
0,63
0,71
0,85
Interest and investment income
-
-
-
-
Interest expense
-128,00 մլն
-121,00 մլն
-111,00 մլն
-108,00 մլն
Net interest expenses
-128,00 մլն
-121,00 մլն
-111,00 մլն
-108,00 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
462,00 մլն
340,00 մլն
359,00 մլն
403,00 մլն
Gain or loss from assets sale
-
-
-81,00 մլն
-
AI content may include mistakes. Learn more
Google Apps